Fagron Compounding Services recalled 109,320 syringes of bevacizumab (Avastin) on August 29, 2025. The recall follows a lack of assurance of sterility, posing a high health risk. Consumers and healthcare providers should stop using the product immediately.
Lack of Assurance of Sterility
Consumers and healthcare providers should stop using this product immediately. Contact Fagron Compounding Services or your healthcare provider for guidance. Notification method: Letter
The product is bevacizumab (Avastin) Injection, 1.25mg/0.05mL in sterile single-dose syringes. It was distributed nationwide in the USA. The recall includes lot numbers C274-000044756, C274-000044757, and others with expiration dates ranging from September 13, 2025, to September 20, 2025.
The recall was initiated due to a lack of assurance of sterility, which can lead to serious infections or complications. The FDA classified this recall as Class II, indicating a risk of temporary or medically reversible adverse health consequences.
No specific incidents or injuries have been reported related to this recall. The absence of sterility assurance raises concerns for potential infections.
Stop using the recalled product immediately. Consumers should contact Fagron Compounding Services or their healthcare provider for guidance on the next steps.
For more information, contact Fagron Compounding Services. Visit their website or call for assistance.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.